肿瘤学与转化医学（英文）2024，Vol.10Issue(4)：162-170,9.DOI:10.1097/ot9.0000000000000041
Tumor-infiltrating T-Lymphocyte immunity-related immune tolerance and anti-programmed cell death protein 1/ligand of programmed cell death protein 1 therapy for advanced hepatocellular carcinoma
Tumor-infiltrating T-Lymphocyte immunity-related immune tolerance and anti-programmed cell death protein 1/ligand of programmed cell death protein 1 therapy for advanced hepatocellular carcinoma
Lingzhen Hu 1Zongren Wang 1Yang Liao 1Xiaomeng Jiang 1Huojun Lian 1Zhuoying Lin1
作者信息
- 1. Department of Gastroenterology,Shangrao People's Hospital,Shangrao 334000,Jiangxi Province,China
- 折叠
摘要
关键词
Anti-PD-1/PD-L1 treatment/Combination therapy/Hepatocellular carcinoma/Immune tolerance/Tumor-infiltrating T lymphocyte immunityKey words
Anti-PD-1/PD-L1 treatment/Combination therapy/Hepatocellular carcinoma/Immune tolerance/Tumor-infiltrating T lymphocyte immunity引用本文复制引用
Lingzhen Hu,Zongren Wang,Yang Liao,Xiaomeng Jiang,Huojun Lian,Zhuoying Lin..Tumor-infiltrating T-Lymphocyte immunity-related immune tolerance and anti-programmed cell death protein 1/ligand of programmed cell death protein 1 therapy for advanced hepatocellular carcinoma[J].肿瘤学与转化医学（英文）,2024,10(4):162-170,9.
